Month: July 2021

HUTCHMED’s Marketing Authorization Application for Surufatinib Submitted and Validated by the European Medicines Agency

Written by Customer Service on July 16, 2021. Posted in Public Companies.

– EMA commences review of surufatinib for the treatment of advanced neuroendocrine tumors – – Expands potential global reach of surufatinib, in addition to China where it is already launched, and in the U.S. where it is under review for marketing approval – HONG KONG, SHANGHAI, China and FLORHAM PARK, N.J., July 15, 2021 (GLOBE NEWSWIRE) — HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; HKEX: 13) today announces that the European Medicines Agency (“EMA”) has validated and accepted its marketing authorization application (“MAA”) for surufatinib for the treatment of pancreatic and extra-pancreatic (non-pancreatic) neuroendocrine tumors (“NETs”). The EMA’s validation confirms that the submission is sufficiently complete and that it is ready to commence the formal review process. The submission follows scientific advice from...

Northern California National Bank Announces Results of Recently Completed Tender Offer by Investors and Reverse Stock Split

Written by Customer Service on July 16, 2021. Posted in Public Companies.

CHICO, Calif., July 15, 2021 (GLOBE NEWSWIRE) — Northern California National Bank (“NorCal” or the “Bank”) announced today the results of the previously announced cash tender offer by investors seeking to acquire all of the outstanding shares of NorCal (the “Investors”), a planned reverse stock split and closing of its stock transfer records during the pendency of the reverse stock split. The tender offer expired at 5:00, p.m., Pacific Time, on July 9, 2021. As of the expiration of the tender offer, a total of 1,364,390 shares of NorCal common stock, representing approximately 94.1% of the outstanding NorCal shares, were validly tendered into and not validly withdrawn from the tender offer. On July 14, 2021, the tender offer was consummated with the Investors now owning 94.1% of the outstanding shares of all the voting capital...

Methanex and Mitsui O.S.K. Lines Announce Agreement on Key Commercial Terms for a Strategic Partnership

Written by Customer Service on July 16, 2021. Posted in Public Companies.

“Taranaki Sun” Methanol Dual-fueled Methanol Carrier VesselIn 2016, Methanex, WFS and MOL, in conjunction with other key partners, jointly built the first ocean-going dual-fuel vessels, including the Taranaki Sun, capable of running on methanolVANCOUVER, British Columbia and TOKYO, July 15, 2021 (GLOBE NEWSWIRE) — Methanex Corporation (TSX:MX) (NASDAQ:MEOH) (Methanex) and Mitsui O.S.K. Lines, Ltd. (TSE:9104) (MOL) are pleased to announce that the parties have concluded Key Commercial Terms for the purchase and sale of an equity position in, and the establishment of a strategic partnership involving, Methanex’s Waterfront Shipping (WFS) subsidiary. With a fleet of approximately 800 vessels, MOL is one of the world’s largest shipping companies. WFS is a global marine transportation company and operates the world’s...

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results

Written by Customer Service on July 15, 2021. Posted in Earnings Releases And Operating Results.

OLDSMAR, Fla., July 15, 2021 (GLOBE NEWSWIRE) — Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal second quarter ended May 31, 2021. Financial Results Revenue Consolidated revenues for the second quarter of fiscal 2021 were $7.21 million compared to $7.87 million for the second quarter of fiscal 2020, an 8% decrease. The revenues for the second quarter of fiscal 2021 consisted of $7.16 million in processing and storage fee revenue and $46,000 in public banking revenue compared to $7.40 million in processing and storage fee revenue, $57,000 in product revenue, $214,000 in public banking revenue and $202,000 in license and royalty income for the second quarter of fiscal 2020. Net Income The...

Apollo Clarifies Certain Technical Disclosure

Written by Customer Service on July 15, 2021. Posted in Public Companies.

VANCOUVER, British Columbia, July 15, 2021 (GLOBE NEWSWIRE) — Apollo Gold & Silver Corp. (“Apollo” or the “Company”) (TSX.V: APGO) as a result of a review by the British Columbia Securities Commission, is issuing the following news release to clarify its recent disclosure relating to historical resources on the projects it acquired in its transaction with Stronghold Silver Corp. The Company confirms the existence of historical estimates on the Waterloo and Langtry, as follows:Property Source Category Grade Tonnes Cutoff OuncesWaterloo Pan American 2013 Inferred 86 g/t Ag 37,079,349 20 g/t Ag 102,953,457Langtry Moran et al., 2012 Indicated 1.48 opt Ag 12,700,000 0.76 opt Ag 18,809,000 Inferred 1.40 opt Ag 30,400,000 0.76 opt Ag 42,623,000(1). Reference to historic resources at Waterloo Project, refer to...

Arrival to Report Second Quarter 2021 Financial Results on August 12, 2021; Reminder of Deadline for Public Warrant Redemption July 19, 2021

Written by Customer Service on July 15, 2021. Posted in Public Companies.

LUXEMBOURG, July 15, 2021 (GLOBE NEWSWIRE) — Arrival (NASDAQ: ARVL), the company creating electric vehicles (“EVs”) with its unique technologies, today announced that it will report financial results for the second quarter ending June 30, 2021 before the U.S. markets open on Thursday, August 12, 2021. The Company will host a corresponding webinar at 8:00 a.m. Eastern Time on that day. The live webinar will be accessible on the Company’s website at investors.arrival.com. A replay will be available approximately two hours after the conclusion of the live event. Separately, Arrival reminds public warrant holders that the Company has elected to redeem all of the outstanding public warrants that were issued in connection with its business combination with CIIG Merger Corp., and registered holders will have until 5:00 p.m. New York City...

TScan Therapeutics, Inc. Announces Pricing of Initial Public Offering

Written by Customer Service on July 15, 2021. Posted in Public Companies.

WALTHAM, Mass., July 15, 2021 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (TScan), a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer, today announced the pricing of its initial public offering of 6,666,667 shares of common stock at a public offering price of $15.00 per share, for gross proceeds of $100.0 million, before underwriting discounts, commissions, and offering expenses payable by TScan. In addition, TScan has granted the underwriters an option for a period of 30 days to purchase up to 1,000,000 additional shares of common stock at the initial public offering price, less underwriting discounts and commissions. All shares are being offered and sold by TScan. TScan’s common stock is expected to begin trading on The...

FibroGen Announces Outcome of FDA Advisory Committee Review of Roxadustat for Treatment of Anemia of Chronic Kidney Disease

Written by Customer Service on July 15, 2021. Posted in Public Companies.

SAN FRANCISCO, July 15, 2021 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) today announced that the U.S. Food and Drug Administration (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) voted to recommend not approving roxadustat, an oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor, for the treatment of anemia due to chronic kidney disease (CKD) in adult patients. The Committee based its recommendation on data from a global Phase 3 program encompassing more than 8,000 patients. While the FDA is not required to follow the Committee’s vote, the agency considers the Committee’s non-binding recommendations when making its decision. “While we are disappointed with today’s outcome,” said Enrique Conterno, Chief Executive Officer, FibroGen, “we believe the scientific evidence supports...

Melcor REIT announces July distribution of $0.035 per unit; announces Q2-2021 conference call details

Written by Customer Service on July 15, 2021. Posted in Dividend Reports And Estimates.

EDMONTON, Alberta, July 15, 2021 (GLOBE NEWSWIRE) — Melcor Real Estate Investment Trust (TSX: MR.UN) today announced that the Trustees of the REIT have declared cash distributions of $0.035 per unit for the month of July 2021, unchanged from previous months. The REIT will be re-evaluating its distribution at its upcoming second quarter meeting at which time mid-year re-forecast information will be reviewed in order to establish a comfortable and sustainable distribution. The July distribution will be payable as follows:Month Record Date Distribution Date Distribution AmountJuly 2021 July 30, 2021 August 16, 2021 $0.035 per unitMelcor REIT also announced that results for the second quarter ended June 30, 2021 will be released on July 27, 2021 after market close. Management will host a conference call at 11:00 am ET (9:00...

Grom Social Enterprises, Inc. Announces Full Exercise of Over-Allotment Option in Public Offering

Written by Customer Service on July 15, 2021. Posted in Public Companies.

BOCA RATON, July 15, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Grom Social Enterprises, Inc. (NASDAQ: GROM) (“Grom”, the “Company”), a social media platform and original content provider for children under the age of 13, today announced that the underwriters of its previously completed public offering have exercised the remainder of their over-allotment option to purchase an additional 361,445 shares. The 45-day over-allotment option was granted in connection with the Company’s previously announced underwritten public offering of 2,409,639 units at a public offering price of $4.15 per unit. After giving effect to the full exercise of the over-allotment option, the total number of units sold by the Company in the offering increased to 2,711,084 units, resulting in aggregate gross proceeds of approximately $11.5 million prior...

Month: July 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals